Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 97951-98000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04701749
Study of the Effects of Anticoagulant Interruption Covered by Percutaneous Left Atrial Occlusion in Patients With Chronic Atrial Fibrillation and Radiation Cystitis at Risk of Bleeding
N/ARecruiting
40 participants
Started: Feb 24, 2021 · Completed: Sep 30, 2030
2 conditions1 sponsor1 location
NCT04788823
The Impact of Prednisone on Semen Parameters and Pregnancy Rates Post Vasectomy Reversal
PHASE4Active, not recruiting
100 participants
Started: Feb 24, 2021 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06861257
Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients
N/ARecruiting
70 participants
Started: Feb 24, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor10 locations
NCT04674813
A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma
PHASE1Active, not recruiting
180 participants
Started: Feb 24, 2021 · Completed: Dec 8, 2025
1 condition1 sponsor10 locations
NCT05713448
Prevalence of Overweight and Obesity in Adult Patients Suffering From Type 1 Diabetes
N/ARecruiting
100,000 participants
Started: Feb 24, 2021 · Completed: Dec 29, 2099
2 conditions1 sponsor1 location
NCT04559139
Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer
PHASE2/PHASE3Active, not recruiting
186 participants
Started: Feb 24, 2021 · Completed: Jun 30, 2029
6 conditions2 sponsors367 locations
NCT04762199
MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
PHASE1Recruiting
69 participants
Started: Feb 24, 2021 · Completed: Dec 27, 2026
5 conditions2 sponsors1 location
NCT04031573
Ivabradine for Heart Rate Control In Septic Shock
PHASE3Recruiting
429 participants
Started: Feb 24, 2021 · Completed: Dec 24, 2024
1 condition1 sponsor1 location
NCT04760769
Open-label Trial in Parkinson's Disease (PD)
PHASE3Active, not recruiting
992 participants
Started: Feb 24, 2021 · Completed: Jan 31, 2026
1 condition1 sponsor140 locations
NCT04777422
Defibrotide in Children With High Risk Kawasaki Disease
PHASE2Active, not recruiting
2 participants
Started: Feb 24, 2021 · Completed: Jun 30, 2024
1 condition4 sponsors3 locations
NCT04450173
Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma
PHASE2Recruiting
40 participants
Started: Feb 24, 2021 · Completed: Apr 30, 2026
6 conditions4 sponsors4 locations
NCT04519866
Clinical Trial of Electroacupuncture in Axial Spondyloarthritis (E-AcuSpA)
NARecruiting
100 participants
Started: Feb 24, 2021 · Completed: Dec 31, 2025
2 conditions4 sponsors1 location
NCT04658303
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
N/ARecruiting
20 participants
Started: Feb 24, 2021 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT04851925
MR Fingerprinting for Vestibular Schwannomas
N/ARecruiting
50 participants
Started: Feb 24, 2021 · Completed: Dec 24, 2025
1 condition1 sponsor1 location
NCT06133920
Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures
N/ARecruiting
40 participants
Started: Feb 24, 2021 · Completed: Feb 1, 2027
2 conditions1 sponsor1 location
NCT04943328
Cemented TrendHip® - Multicenter PMCF Study on Total Indications
NAActive, not recruiting
119 participants
Started: Feb 23, 2021 · Completed: May 8, 2028
6 conditions1 sponsor4 locations
NCT04745689
Study of AZD2811 + Durvalumab in ES-SCLC
PHASE2Active, not recruiting
31 participants
Started: Feb 23, 2021 · Completed: Dec 1, 2025
1 condition1 sponsor12 locations
NCT04279847
Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
PHASE1Active, not recruiting
140 participants
Started: Feb 23, 2021 · Completed: Dec 30, 2026
7 conditions1 sponsor48 locations
NCT06801249
Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome
PHASE4Recruiting
50 participants
Started: Feb 23, 2021 · Completed: Feb 17, 2025
2 conditions1 sponsor3 locations
NCT05100420
Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository
N/AEnrolling by invitation
2,000 participants
Started: Feb 23, 2021 · Completed: Aug 23, 2027
4 conditions2 sponsors13 locations
NCT04913415
A Study to Evaluate Routine Chest Tube Management After Minimally Invasive Lung Surgery
NAActive, not recruiting
160 participants
Started: Feb 23, 2021 · Completed: Aug 31, 2024
1 condition1 sponsor1 location
NCT04731961
Reduction in Number of Botox Injections for Urgency Urinary Incontinence
NARecruiting
56 participants
Started: Feb 23, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT03899636
A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer
PHASE3Active, not recruiting
528 participants
Started: Feb 23, 2021 · Completed: Apr 30, 2025
1 condition1 sponsor6 locations
NCT04255849
Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIV
PHASE3Active, not recruiting
700 participants
Started: Feb 23, 2021 · Completed: Jan 31, 2026
3 conditions8 sponsors3 locations
NCT04685135
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
PHASE3Active, not recruiting
453 participants
Started: Feb 23, 2021 · Completed: Jul 2, 2026
2 conditions1 sponsor343 locations
NCT04743752
Obstructive Sleep Apnea Influences Efficacy of PD-1-Based Immunotherapy Against Non-Small Cell Lung Cancer
N/ARecruiting
200 participants
Started: Feb 23, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04736199
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancer
PHASE3Active, not recruiting
669 participants
Started: Feb 23, 2021 · Completed: Jan 30, 2026
1 condition2 sponsors131 locations
NCT04704219
Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)
PHASE2Active, not recruiting
160 participants
Started: Feb 23, 2021 · Completed: Oct 25, 2025
1 condition2 sponsors56 locations
NCT04524247
Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies
NARecruiting
100 participants
Started: Feb 23, 2021 · Completed: Jul 2, 2032
4 conditions1 sponsor1 location
NCT04644575
Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A
PHASE3Active, not recruiting
261 participants
Started: Feb 23, 2021 · Completed: Jan 15, 2027
1 condition1 sponsor85 locations
NCT04727307
Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial
PHASE2Recruiting
202 participants
Started: Feb 23, 2021 · Completed: Feb 28, 2031
1 condition1 sponsor19 locations
NCT05426447
Protein and Performance (PROPER) in Endurance Athletes
NAActive, not recruiting
20 participants
Started: Feb 23, 2021 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT04636879
Dry Needling and Patients Treatment Expectations
NARecruiting
45 participants
Started: Feb 23, 2021 · Completed: Sep 5, 2025
1 condition1 sponsor1 location
NCT04453917
Dynamics of T Cell Expression of Immune Checkpoint Molecules in Progressive Multifocal Leukoencephalopathy
NARecruiting
15 participants
Started: Feb 23, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor4 locations
NCT04633252
M9241 in Combination With Docetaxel in Adults With Metastatic Castration Sensitive and Castration Resistant Prostate Cancer
PHASE1/PHASE2Recruiting
86 participants
Started: Feb 23, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT04721015
Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors
PHASE1Active, not recruiting
81 participants
Started: Feb 23, 2021 · Completed: Feb 28, 2026
2 conditions1 sponsor33 locations
NCT04408638
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
PHASE3Active, not recruiting
270 participants
Started: Feb 23, 2021 · Completed: Feb 15, 2026
1 condition1 sponsor62 locations
NCT05034146
68Ga-FAPI PET/CT in Malignant Tumors
NARecruiting
500 participants
Started: Feb 23, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT04208490
Implementation and Effectiveness Trial of HN-STAR
NAActive, not recruiting
357 participants
Started: Feb 23, 2021 · Completed: Feb 28, 2027
1 condition3 sponsors49 locations
NCT04702373
Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT
PHASE3Active, not recruiting
144 participants
Started: Feb 23, 2021 · Completed: Dec 30, 2024
1 condition2 sponsors10 locations
NCT05221853
Real-time MRI for Evaluating Cardiac Volumetry
N/ARecruiting
570 participants
Started: Feb 23, 2021 · Completed: Feb 1, 2025
1 condition1 sponsor1 location
NCT04780659
COVID-19 Vaccination of Immunodeficient Persons (COVAXID)
PHASE4Active, not recruiting
540 participants
Started: Feb 23, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04767646
Evaluation of the Relationship Between the Duration of the Evolution of the Complex Regional Pain Syndrome Type 1 (CRPS 1) and Effectiveness of the Continuous Peripheral Nerve Block (CPNB) Associated With an Intensive Rehabilitation Program
NARecruiting
30 participants
Started: Feb 23, 2021 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT04793269
Characteristics of Long COVID-19 Syndrome
N/AActive, not recruiting
200 participants
Started: Feb 23, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04217304
SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial
PHASE2Recruiting
60 participants
Started: Feb 23, 2021 · Completed: May 1, 2026
1 condition2 sponsors1 location
NCT04242823
Primary HPV-based Cervical Cancer Screening Algorithms in Botswana
NAActive, not recruiting
3,000 participants
Started: Feb 22, 2021 · Completed: Feb 1, 2027
2 conditions3 sponsors1 location
NCT03870802
MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)
N/ARecruiting
40 participants
Started: Feb 22, 2021 · Completed: Nov 15, 2024
1 condition1 sponsor1 location
NCT05116449
Comparison of Changes in the Quality of Life of Patients Operated on Breast Cancer at the Drôme Ardèche Breast Institute According to Access to Supportive Oncological Care (IDSein)
N/ARecruiting
310 participants
Started: Feb 22, 2021 · Completed: Jan 22, 2026
1 condition2 sponsors2 locations
NCT05135949
Strength After Elbow Fractures in the Elderly
N/ARecruiting
50 participants
Started: Feb 22, 2021 · Completed: Jul 1, 2027
1 condition1 sponsor1 location
NCT04347161
Implementation Strategies for Monitoring Adherence in Real Time
NAActive, not recruiting
75 participants
Started: Feb 22, 2021 · Completed: Oct 20, 2025
3 conditions3 sponsors1 location